Posts Tagged: medical devices

OtoSim featured in Health Research & Innovation, receives B Corp Designation (video)

OtoSim Inc., a MaRS Innovation spin-of company, was featured along with MaRS Innovation in the Autumn 2012 edition of Health Research & Innovation magazine. The article by Tim Wilson is titled: "The Business of Health Innovation: How Startups Find Funding." Here's an excerpt: "The doctors [Vito Forte and Paolo Campisi] designed OtoSim and did a clinical validation on the prototype, says Andrew Sinclair, OtoSim's CEO. "They then disclosed the invention to SickKids, who passed it to MaRS Innovation, which is a partnership of the ... Read more

Gen Magazine features Dr. Aaron Wheeler’s research in microfluidics

GEN Magazine (Genetic Engineering and Biotechnology News) featured the microfluidics research of Dr. Aaron Wheeler on November 15, 2012. Wheeler, Canada Research Chair of Bioanalytical Chemistry and an associate professor at the University of Toronto, has made an invention disclosure to MaRS Innovation; Kapplex is the start-up company created to commercialize his research. (more…) Read more

Raphael Hofstein’s editorial in National Post’s Medical Devices supplement

MaRS Innovation's President and CEO, Raphael Hofstein, has published an editorial outlining the challenges facing entrepreneurs seeking to bring new healthcare innovations to market for the National Post's Medical Devices supplement. The article, titled "Investing in innovation for a healthier Canada," is available on page 2 of the Post supplement. Posted by Elizabeth Monier-Williams, marketing and communications officer. Read more

ApneaDX Inc: A Medical Device to Accurately Diagnose Sleep Apnea at Home

MaRS Innovation and the University Health Network's Toronto Rehabilitation Institute have collaborated to bring a new technology to market that accurately diagnoses sleep apnea at the patient's home. Sleep apnea is a medical disorder that is gaining increasing recognition as a major health issue. It is estimated that six to eight per cent of the world's population suffer from the disease, but 85 per cent are undiagnosed. Undiagnosed sleep apnea is estimated to cause $3.4 billion in additional medical costs in the US.  ... Read more
Page 3 of 3123